oncolyt adenovirus ad promise tool cancer therapeutic abbas therapy until spec c serotyp adenoviru type commonly employ prior clinic trial demons low office vector mainly due absence primary receptor coxsacki car cell engine serotyp chime receptor greatly improv potent translate infectivityenhanc challenge lack replica permits anim model studi explore pig model perform fibermodifi control fiberunmodifi virus use analyze bind gene transfer cytolyt bail various inhuman cell line marin hamster cabin portion among test support active syrian show revid product viral infect transduct outperform phenomenon often observe human subset value vivo immunocompet quantity per analyst day post reveal dna replicationdepend luciferas active swine lung spleen india tissue studi flaw use hamster test first report valid pig valuable prelim until hope data help foster include retarget trois 